Efficacy and safety of Synolis VA for hip osteoarthritis
Official title: 6-month Evaluation of the Efficacy and Safety of Synolis VA 80/160 in the Treatment of Symptomatic Hip Osteoarthritis
Run by Aptissen SA · NCT05829733 · Data updated 2026-11-12
This study is testing if a new treatment called Synolis VA can help people with hip osteoarthritis feel less pain and move better over six months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Aptissen SA Industry-sponsored |
| Locations | 3 sites (Belfort and 2 other locations) |
| Status | Recruiting |
| Started | May 27, 2024 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | December 12, 2025 |
| Trial ID | NCT05829733 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with a diagnosis of hip osteoarthritis who have not responded to standard analgesics or NSAIDs.
✕Probably not a fit
Patients who are pregnant, have had recent infections in the affected joint, or are scheduled for hip surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter study evaluates the efficacy and safety of Synolis VA 80/160 in patients with hip osteoarthritis over a 6-month period. Participants will receive the treatment and be monitored for improvements in hip pain and function, as well as any potential side effects. The study aims to determine whether this hyaluronic acid-based intervention can provide relief for patients who have not responded adequately to other treatments.
Why it matters
Potential benefit: If successful, this treatment could significantly improve pain management and quality of life for patients suffering from hip osteoarthritis.
How similar studies have gone: Previous studies on hyaluronic acid treatments for osteoarthritis have shown varying degrees of success, indicating potential but also the need for further investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient over 18 years of age, * Patient with osteoarthritis of the hip. The diagnosis is based on the following criteria: * Treated hip pain: Oxford score ≥ 21/60, * Kellgren-Lawrence positive X-ray stage: II - III (inclusion radiograph dated no more than 6 months before the inclusion visit), * Symptoms related to osteoarthritis of the hip for at least 2 months, * Failure of treatments (i.e., inadequate or ineffective response to analgesics and/or NSAIDs or intolerance to NSAIDs or low-grade opioids (leaving an OXFORD score ≥ 21/60), * Informed consent form signed by the patient, * The patient has never had a visco supplement injection or corticosteroid injection in the hip to be treated (or more than 6 months old). Exclusion Criteria: * Pregnancy, * Participation in another clinical trial, * Skin lesion near the injection site, * Recent or old infection of the affected joint, * Patient with a programmed arthroplasty, * Patient with a pathology that makes decision-making impossible, * The patient must not have undergone non-prosthetic hip-conserving surgery such as osteotomy or arthroscopy less than 12 months old.
Where it's running
-
Service de Rhumatologie, Hôpital Nord Franche-Comté
Belfort, France Recruiting -
Service de chirurgie orthopédique et traumatologie Centre Hospitalier de Dunkerque CHD
Dunkirk, France Recruiting -
Service d'Orthopédie II (Membre Inférieur, Chirurgie du Sport et Chirurgie Septique) Hôpital Salengro, CHRU de Lille
Lille, France Recruiting
Study contacts
- Study coordinator: Eduard Vidovic, MD
- Email: clinic@aptissen.com
- Phone: +41225522104
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collarless Actis hip stem for cementless hip replacement in Asian patients
This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.
-
Intravenous dexamethasone for better pain control after hip replacement with a PENG block
This study tests whether giving dexamethasone through a vein, in 0, 4, or 8 mg doses, helps control pain after total hip arthroplasty when used with a PENG block.
-
Comparing barbed and conventional wound closure after hip or knee replacement
This study will test whether barbed sutures or conventional sutures lead to better wound healing and fewer complications for adults having primary or aseptic revision hip or knee replacement.
-
Choose to Move Replacement Ready for people waiting for hip or knee replacement
This project will test whether the Choose to Move Replacement Ready program helps older adults on hip or knee replacement waitlists increase physical activity, improve mobility, and support psychosocial health.
-
Oral CBD and THC for hip or knee osteoarthritis pain
This study will test whether taking a daily oral CBD or THC capsule can reduce pain interference in adults aged 40–80 with hip or knee osteoarthritis.
-
Evaluating colchicine's effect on knee and hip replacements in osteoarthritis patients
This study is testing if taking colchicine every day can help people with osteoarthritis avoid needing knee or hip replacement surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.